Project Details
Description
Protocol Chair for "A randomized, double masked, placebo-controlled, dose escalation study to evaluate the safety and efficacy of immunotherapy with multiple peptides (MultiPepT1De) in pediatric participants with new-onset Type 1 diabetes (iMMPepBeta)
Status | Finished |
---|---|
Effective start/end date | 8/1/21 → 3/14/23 |
Funding
- JAEB CENTER FOR HEALTH RESEARCH
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.